China Healthwise Holdings Limited (0348.HK)
HKD 0.1
(-1.04%)
HKD 0.1
(-1.04%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 145.27 Million HKD | -2.51% |
| 2022 | 149.01 Million HKD | 23.12% |
| 2021 | 121.03 Million HKD | -12.29% |
| 2020 | 137.98 Million HKD | -49.22% |
| 2019 | 271.75 Million HKD | -10.71% |
| 2018 | 304.35 Million HKD | -12.04% |
| 2017 | 346.02 Million HKD | 43.13% |
| 2016 | 241.75 Million HKD | 34.34% |
| 2015 | 179.95 Million HKD | 53.87% |
| 2014 | 116.95 Million HKD | 72.58% |
| 2013 | 67.76 Million HKD | -8.16% |
| 2012 | 73.78 Million HKD | -43.56% |
| 2011 | 130.74 Million HKD | -73.06% |
| 2010 | 485.29 Million HKD | 33.08% |
| 2009 | 364.67 Million HKD | -19.94% |
| 2008 | 455.48 Million HKD | -17.21% |
| 2007 | 550.19 Million HKD | -4.46% |
| 2006 | 575.86 Million HKD | -1.81% |
| 2005 | 586.48 Million HKD | -2.9% |
| 2004 | 604.01 Million HKD | 30.71% |
| 2003 | 462.09 Million HKD | 7.24% |
| 2002 | 430.91 Million HKD | 19.84% |
| 2001 | 359.57 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 133.69 Million HKD | -7.97% |
| 2024 Q2 | 133.69 Million HKD | 0.0% |
| 2023 Q1 | 126.85 Million HKD | -14.87% |
| 2023 FY | 145.27 Million HKD | -2.51% |
| 2023 Q4 | 145.27 Million HKD | 0.0% |
| 2023 Q2 | 126.85 Million HKD | 0.0% |
| 2023 Q3 | 145.27 Million HKD | 14.52% |
| 2022 Q2 | 127.89 Million HKD | 0.0% |
| 2022 Q1 | 127.89 Million HKD | 5.67% |
| 2022 FY | 149.01 Million HKD | 23.12% |
| 2022 Q4 | 149.01 Million HKD | 0.0% |
| 2022 Q3 | 149.01 Million HKD | 16.51% |
| 2021 Q2 | 117.54 Million HKD | 0.0% |
| 2021 FY | 121.03 Million HKD | -12.29% |
| 2021 Q4 | 121.03 Million HKD | 0.0% |
| 2021 Q1 | 117.54 Million HKD | -14.81% |
| 2021 Q3 | 121.03 Million HKD | 2.96% |
| 2020 Q1 | 271.18 Million HKD | 0.0% |
| 2020 Q2 | 271.18 Million HKD | 0.0% |
| 2020 Q4 | 137.98 Million HKD | 0.0% |
| 2020 Q3 | 137.98 Million HKD | -49.12% |
| 2020 FY | 137.98 Million HKD | -49.22% |
| 2019 FY | 271.75 Million HKD | -10.71% |
| 2019 Q3 | 414.11 Million HKD | 0.0% |
| 2019 Q1 | 304.35 Million HKD | 0.0% |
| 2018 Q3 | 413.32 Million HKD | 5.19% |
| 2018 FY | 304.35 Million HKD | -12.04% |
| 2018 Q2 | 392.91 Million HKD | 13.55% |
| 2018 Q1 | 346.02 Million HKD | 6.41% |
| 2017 Q3 | 419.38 Million HKD | 4.79% |
| 2017 Q2 | 400.21 Million HKD | 65.55% |
| 2017 Q1 | 241.75 Million HKD | 8.01% |
| 2017 Q4 | 325.17 Million HKD | -22.46% |
| 2017 FY | 346.02 Million HKD | 43.13% |
| 2016 Q4 | 223.83 Million HKD | -25.8% |
| 2016 FY | 241.75 Million HKD | 34.34% |
| 2016 Q1 | 179.95 Million HKD | 10.52% |
| 2016 Q2 | 283.73 Million HKD | 57.67% |
| 2016 Q3 | 301.66 Million HKD | 6.32% |
| 2015 Q4 | 162.83 Million HKD | -19.85% |
| 2015 FY | 179.95 Million HKD | 53.87% |
| 2015 Q1 | 116.95 Million HKD | 0.0% |
| 2015 Q3 | 203.16 Million HKD | 0.0% |
| 2015 Q2 | 203.16 Million HKD | 73.72% |
| 2014 Q4 | 116.95 Million HKD | -42.87% |
| 2014 Q2 | 204.72 Million HKD | 202.11% |
| 2014 Q1 | 67.76 Million HKD | 0.0% |
| 2014 FY | 116.95 Million HKD | 72.58% |
| 2014 Q3 | 204.72 Million HKD | 0.0% |
| 2013 Q4 | 67.76 Million HKD | -43.11% |
| 2013 FY | 67.76 Million HKD | -8.16% |
| 2013 Q3 | 119.12 Million HKD | 15.13% |
| 2013 Q2 | 103.47 Million HKD | 40.23% |
| 2013 Q1 | 73.78 Million HKD | 13.06% |
| 2012 Q1 | 130.74 Million HKD | 0.0% |
| 2012 FY | 73.78 Million HKD | -43.56% |
| 2012 Q2 | 104.29 Million HKD | -20.23% |
| 2012 Q3 | 112.68 Million HKD | 8.05% |
| 2012 Q4 | 65.26 Million HKD | -42.08% |
| 2011 Q1 | 485.29 Million HKD | 0.0% |
| 2011 Q3 | 140.09 Million HKD | 0.0% |
| 2011 Q4 | 130.74 Million HKD | -6.67% |
| 2011 FY | 130.74 Million HKD | -73.06% |
| 2010 Q1 | 364.67 Million HKD | 0.0% |
| 2010 FY | 485.29 Million HKD | 33.08% |
| 2010 Q3 | 502.49 Million HKD | 0.0% |
| 2009 Q1 | 455.48 Million HKD | 0.0% |
| 2009 FY | 364.67 Million HKD | -19.94% |
| 2009 Q3 | 469.25 Million HKD | 0.0% |
| 2008 FY | 455.48 Million HKD | -17.21% |
| 2007 FY | 550.19 Million HKD | -4.46% |
| 2006 FY | 575.86 Million HKD | -1.81% |
| 2005 FY | 586.48 Million HKD | -2.9% |
| 2004 FY | 604.01 Million HKD | 30.71% |
| 2003 FY | 462.09 Million HKD | 7.24% |
| 2002 FY | 430.91 Million HKD | 19.84% |
| 2001 FY | 359.57 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Tycoon Group Holdings Limited | 445.4 Million HKD | 67.384% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 413.75 Million HKD | 64.889% |